Immuneering Corporation
IMRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$61 | -$53 | -$51 | -$34 |
| Dep. & Amort. | $0 | $0 | $1 | $0 |
| Deferred Tax | $0 | $0 | $0 | -$0 |
| Stock-Based Comp. | $7 | $6 | $0 | $2 |
| Change in WC | -$1 | -$1 | $2 | $1 |
| Other Non-Cash | $0 | -$1 | $4 | $0 |
| Operating Cash Flow | -$55 | -$49 | -$44 | -$31 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$1 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$5 | -$45 | -$50 | -$76 |
| Inv. Sales/Matur. | $32 | $52 | $93 | $76 |
| Other Inv. Act. | $0 | $0 | $0 | -$76 |
| Investing Cash Flow | $26 | $7 | $42 | -$76 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $4 | $28 | $0 | $120 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $0 | $0 | $24 |
| Financing Cash Flow | $5 | $28 | $0 | $144 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$23 | -$13 | -$2 | $38 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $59 | $73 | $75 | $37 |
| End Cash | $36 | $59 | $73 | $75 |
| Free Cash Flow | -$55 | -$49 | -$45 | -$31 |